Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention

被引:97
|
作者
Tong, Xin [1 ]
Pelling, Jill C.
机构
[1] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA
关键词
Akt; mTOR; apigenin; cancer; CELL-CYCLE ARREST; CHEMOPREVENTIVE BIOFLAVONOID APIGENIN; CYCLOOXYGENASE-2; COX-2; EXPRESSION; SIGNAL-TRANSDUCTION PATHWAYS; GLUTATHIONE-S-TRANSFERASE; HUMAN PANCREATIC-CANCER; CYTOCHROME-C RELEASE; FLAVONOID APIGENIN; DIETARY FLAVONOIDS; TUMOR-CELLS;
D O I
10.2174/18715206113139990119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural products are important sources of anti-cancer lead molecules, and high dietary consumption of fruits and vegetables is associated with a reduced risk of certain cancers. Many efforts have been devoted to identifying and developing plant-derived dietary constituents as chemopreventive agents. Among them, apigenin, a naturally occurring flavonoid found in a variety of fruits and leafy vegetables, has been shown to possess remarkable anti-oxidant, anti-inflammatory and anti-carcinogenic properties. This review summarizes the anti-cancer and chemopreventive effects of apigenin at cellular and molecular levels, its chemical structure and properties, with focus on mechanism related to apigenin's inhibition of the PI3K/Akt/mTOR signaling pathways.
引用
收藏
页码:971 / 978
页数:8
相关论文
共 50 条
  • [21] Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology
    Serej, Forough Alemi
    Pourhassan-Moghaddam, Mohammad
    Kalan, Mohammad Ebrahimi
    Mehdipour, Ahmad
    Serej, Zeynab Aliyari
    Ebrahimi-Kalan, Abbas
    CRESCENT JOURNAL OF MEDICAL AND BIOLOGICAL SCIENCES, 2018, 5 (01): : 7 - 13
  • [22] Targeting PI3K/AKT/mTOR signaling to overcome drug resistance in cancer
    Tufail, Muhammad
    Wan, Wen-Dong
    Jiang, Canhua
    Li, Ning
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 396
  • [23] Dual targeting of the PI3K/Akt/mTOR pathway as an antitumor strategy in Waldenstrom macroglobulinemia
    Roccaro, Aldo M.
    Sacco, Antonio
    Husu, Emanuel N.
    Pitsillides, Costas
    Vesole, Steven
    Azab, Abdel Kareem
    Azab, Feda
    Melhem, Molly
    Ngo, Hai T.
    Quang, Phong
    Maiso, Patricia
    Runnels, Judith
    Liang, Mei-Chih
    Wong, Kwok-Kin
    Lin, Charles
    Ghobrial, Irene M.
    BLOOD, 2010, 115 (03) : 559 - 569
  • [24] Targeting PI3K/mTOR Signaling in Cancer
    Emerling, Brooke M.
    Akcakanat, Argun
    CANCER RESEARCH, 2011, 71 (24) : 7351 - 7359
  • [25] Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
    Morgos, Diana-Theodora
    Stefani, Constantin
    Miricescu, Daniela
    Greabu, Maria
    Stanciu, Silviu
    Nica, Silvia
    Stanescu-Spinu, Iulia-Ioana
    Balan, Daniela Gabriela
    Balcangiu-Stroescu, Andra-Elena
    Coculescu, Elena-Claudia
    Georgescu, Dragos-Eugen
    Nica, Remus Iulian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [26] Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
    Ciruelos Gil, Eva Maria
    CANCER TREATMENT REVIEWS, 2014, 40 (07) : 862 - 871
  • [27] Targeting the PI3K/Akt/mTOR Pathway in Ocular Neovascularization
    Sasore, Temitope
    Reynolds, Alison L.
    Kennedy, Breandan N.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2014, 801 : 805 - 811
  • [28] Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway
    Feng, Li-Min
    Wang, Xue-Feng
    Huang, Qing-Xian
    JOURNAL OF BIOSCIENCES, 2017, 42 (04) : 547 - 554
  • [29] Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
    Akbarzadeh, Maryam
    Mihanfar, Ainaz
    Akbarzadeh, Shabnam
    Yousefi, Bahman
    Majidinia, Maryam
    LIFE SCIENCES, 2021, 285
  • [30] Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain
    Perluigi, Marzia
    Pupo, Gilda
    Tramutola, Antonella
    Cini, Chiara
    Coccia, Raffaella
    Barone, Eugenio
    Head, Elizabeth
    Butterfield, D. Allan
    Di Domenico, Fabio
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (07): : 1144 - 1153